Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M (2008). »Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling«. Mol. Cancer Ther. 7 (10): 3129–3140. doi:10.1158/1535-7163.MCT-08-0013. PMID18852116.
Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M (2008). »Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling«. Mol. Cancer Ther. 7 (10): 3129–3140. doi:10.1158/1535-7163.MCT-08-0013. PMID18852116.